1 Study Coverage |
|
1.1 Genetic Engineering Drug Product Introduction |
|
1.2 Market by Type |
|
| 1.2.1 Global Genetic Engineering Drug Market Size Growth Rate by Type | |
| 1.2.2 Monoclonal Antibody | |
| 1.2.3 Recombinant Human Erythropoietin | |
| 1.2.4 Recombinant Human Interferon | |
| 1.2.5 Recombinant Human Growth Hormone | |
| 1.2.6 Recombinant Human Insulin | |
1.3 Market by Application |
|
| 1.3.1 Global Genetic Engineering Drug Market Size Growth Rate by Application | |
| 1.3.2 Medicine | |
| 1.3.3 Research | |
| 1.3.4 Industrial | |
| 1.3.5 Agriculture | |
| 1.3.6 Other | |
1.4 Study Objectives |
|
1.5 Years Considered |
|
2 Executive Summary |
|
2.1 Global Genetic Engineering Drug Market Size, Estimates and Forecasts |
|
| 2.1.1 Global Genetic Engineering Drug Revenue 2016-2027 | |
| 2.1.2 Global Genetic Engineering Drug Sales 2016-2027 | |
2.2 Global Genetic Engineering Drug, Market Size by Region: 2016 VS 2021 VS 2027 |
|
2.3 Genetic Engineering Drug Historical Market Size by Region (2016-2021) |
|
| 2.3.1 Global Genetic Engineering Drug Retrospective Market Scenario in Sales by Region: 2016-2021 | |
| 2.3.2 Global Genetic Engineering Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 | |
2.4 Genetic Engineering Drug Market Estimates and Projections by Region (2022-2027) |
|
| 2.4.1 Global Genetic Engineering Drug Sales Forecast by Region (2022-2027) | |
| 2.4.2 Global Genetic Engineering Drug Revenue Forecast by Region (2022-2027) | |
3 Global Genetic Engineering Drug Competitor Landscape by Players |
|
3.1 Global Top Genetic Engineering Drug Manufacturers by Sales |
|
| 3.1.1 Global Genetic Engineering Drug Sales by Manufacturer (2016-2021) | |
| 3.1.2 Global Genetic Engineering Drug Sales Market Share by Manufacturer (2016-2021) | |
3.2 Global Top Genetic Engineering Drug Manufacturers by Revenue |
|
| 3.2.1 Key Genetic Engineering Drug Manufacturers Covered: Ranking by Revenue | |
| 3.2.2 Global Genetic Engineering Drug Revenue by Manufacturers (2016-2021) | |
| 3.2.3 Global Genetic Engineering Drug Revenue Share by Manufacturers (2016-2021) | |
| 3.2.4 Global Genetic Engineering Drug Market Concentration Ratio (CR5 and HHI) (2016-2021) | |
| 3.2.5 Global Top 10 and Top 5 Companies by Genetic Engineering Drug Revenue in 2020 | |
| 3.2.6 Global Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) | |
3.3 Global Genetic Engineering Drug Price by Manufacturers |
|
3.4 Global Genetic Engineering Drug Manufacturing Base Distribution, Product Types |
|
| 3.4.1 Genetic Engineering Drug Manufacturers Manufacturing Base Distribution, Headquarters | |
| 3.4.2 Manufacturers Genetic Engineering Drug Product Type | |
| 3.4.3 Date of International Manufacturers Enter into Genetic Engineering Drug Market | |
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans |
|
4 Breakdown Data by Type (2016-2027) |
|
| 詳情：http://www.5269660.cn/8/29/2021-2027-Global-and-Japan-Genetic-Engineering-Drug-Industry-Analysis-and-Trends-Report.html | |
4.1 Global Genetic Engineering Drug Market Size by Type (2016-2021) |
|
| 4.1.1 Global Genetic Engineering Drug Sales by Type (2016-2021) | |
| 4.1.2 Global Genetic Engineering Drug Revenue by Type (2016-2021) | |
| 4.1.3 Genetic Engineering Drug Average Selling Price (ASP) by Type (2016-2021) | |
4.2 Global Genetic Engineering Drug Market Size Forecast by Type (2022-2027) |
|
| 4.2.1 Global Genetic Engineering Drug Sales Forecast by Type (2022-2027) | |
| 4.2.2 Global Genetic Engineering Drug Revenue Forecast by Type (2022-2027) | |
| 4.2.3 Genetic Engineering Drug Average Selling Price (ASP) Forecast by Type (2022-2027) | |
5 Breakdown Data by Application (2016-2027) |
|
5.1 Global Genetic Engineering Drug Market Size by Application (2016-2021) |
|
| 5.1.1 Global Genetic Engineering Drug Sales by Application (2016-2021) | |
| 5.1.2 Global Genetic Engineering Drug Revenue by Application (2016-2021) | |
| 5.1.3 Genetic Engineering Drug Price by Application (2016-2021) | |
5.2 Genetic Engineering Drug Market Size Forecast by Application (2022-2027) |
|
| 5.2.1 Global Genetic Engineering Drug Sales Forecast by Application (2022-2027) | |
| 5.2.2 Global Genetic Engineering Drug Revenue Forecast by Application (2022-2027) | |
| 5.2.3 Global Genetic Engineering Drug Price Forecast by Application (2022-2027) | |
6 Japan by Players, Type and Application |
|
6.1 Japan Genetic Engineering Drug Market Size YoY Growth 2016-2027 |
|
| 6.1.1 Japan Genetic Engineering Drug Sales YoY Growth 2016-2027 | |
| 6.1.2 Japan Genetic Engineering Drug Revenue YoY Growth 2016-2027 | |
| 6.1.3 Japan Genetic Engineering Drug Market Share in Global Market 2016-2027 | |
6.2 Japan Genetic Engineering Drug Market Size by Players (International and Local Players) |
|
| 6.2.1 Japan Top Genetic Engineering Drug Players by Sales (2016-2021) | |
| 6.2.2 Japan Top Genetic Engineering Drug Players by Revenue (2016-2021) | |
6.3 Japan Genetic Engineering Drug Historic Market Review by Type (2016-2021) |
|
| 6.3.1 Japan Genetic Engineering Drug Sales Market Share by Type (2016-2021) | |
| 6.3.2 Japan Genetic Engineering Drug Revenue Market Share by Type (2016-2021) | |
| 6.3.3 Japan Genetic Engineering Drug Price by Type (2016-2021) | |
6.4 Japan Genetic Engineering Drug Market Estimates and Forecasts by Type (2022-2027) |
|
| 6.4.1 Japan Genetic Engineering Drug Sales Forecast by Type (2022-2027) | |
| 6.4.2 Japan Genetic Engineering Drug Revenue Forecast by Type (2022-2027) | |
| 6.4.3 Japan Genetic Engineering Drug Price Forecast by Type (2022-2027) | |
6.5 Japan Genetic Engineering Drug Historic Market Review by Application (2016-2021) |
|
| 6.5.1 Japan Genetic Engineering Drug Sales Market Share by Application (2016-2021) | |
| 6.5.2 Japan Genetic Engineering Drug Revenue Market Share by Application (2016-2021) | |
| 6.5.3 Japan Genetic Engineering Drug Price by Application (2016-2021) | |
6.6 Japan Genetic Engineering Drug Market Estimates and Forecasts by Application (2022-2027) |
|
| 6.6.1 Japan Genetic Engineering Drug Sales Forecast by Application (2022-2027) | |
| 6.6.2 Japan Genetic Engineering Drug Revenue Forecast by Application (2022-2027) | |
| 6.6.3 Japan Genetic Engineering Drug Price Forecast by Application (2022-2027) | |
7 North America |
|
7.1 North America Genetic Engineering Drug Market Size YoY Growth 2016-2027 |
|
7.2 North America Genetic Engineering Drug Market Facts & Figures by Country |
|
| 7.2.1 North America Genetic Engineering Drug Sales by Country (2016-2021) | |
| 7.2.2 North America Genetic Engineering Drug Revenue by Country (2016-2021) | |
| 7.2.3 U.S. | |
| 7.2.4 Canada | |
8 Asia Pacific |
|
8.1 Asia Pacific Genetic Engineering Drug Market Size YoY Growth 2016-2027 |
|
8.2 Asia Pacific Genetic Engineering Drug Market Facts & Figures by Region |
|
| 8.2.1 Asia Pacific Genetic Engineering Drug Sales by Region (2016-2021) | |
| 8.2.2 Asia Pacific Genetic Engineering Drug Revenue by Region (2016-2021) | |
| 8.2.3 China | |
| 8.2.4 Japan | |
| 8.2.5 South Korea | |
| 8.2.6 India | |
| 8.2.7 Australia | |
| 8.2.8 Australia | |
| 8.2.9 Indonesia | |
| 8.2.10 Thailand | |
| 8.2.11 Malaysia | |
| 8.2.12 Philippines | |
| 8.2.13 Vietnam | |
9 Europe |
|
9.1 Europe Genetic Engineering Drug Market Size YoY Growth 2016-2027 |
|
9.2 Europe Genetic Engineering Drug Market Facts & Figures by Country |
|
| 9.2.1 Europe Genetic Engineering Drug Sales by Country (2016-2021) | |
| 9.2.2 Europe Genetic Engineering Drug Revenue by Country (2016-2021) | |
| 9.2.3 Germany | |
| 9.2.4 France | |
| 9.2.5 U.K. | |
| 9.2.6 Italy | |
10 Latin America |
|
10.1 Latin America Genetic Engineering Drug Market Size YoY Growth 2016-2027 |
|
10.2 Latin America Genetic Engineering Drug Market Facts & Figures by Country |
|
| 10.2.1 Latin America Genetic Engineering Drug Sales by Country (2016-2021) | |
| 10.2.2 Latin America Genetic Engineering Drug Revenue by Country (2016-2021) | |
| 10.2.3 Mexico | |
| 10.2.4 Brazil | |
| 10.2.5 Argentina | |
11 Middle East and Africa |
|
11.1 Middle East and Africa Genetic Engineering Drug Market Size YoY Growth 2016-2027 |
|
11.2 Middle East and Africa Genetic Engineering Drug Market Facts & Figures by Country |
|
| 11.2.1 Middle East and Africa Genetic Engineering Drug Sales by Country (2016-2021) | |
| 11.2.2 Middle East and Africa Genetic Engineering Drug Revenue by Country (2016-2021) | |
| 11.2.3 Turkey | |
| 11.2.4 Saudi Arabia | |
| 11.2.5 U.A.E | |
12 Company Profiles |
|
12.1 Company 1 |
|
| 12.1.1 Company 1 Corporation Information | |
| 12.1.2 Company 1 Description and Business Overview | |
| 12.1.3 Company 1 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.1.4 Company 1 Genetic Engineering Drug Products Offered | |
| 2021-2027全球和日本基因工程藥業分析和趨勢報告 | |
| 12.1.5 Company 1 Recent Development | |
12.2 Company 2 |
|
| 12.2.1 Company 2 Corporation Information | |
| 12.2.2 Company 2 Description and Business Overview | |
| 12.2.3 Company 2 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.2.4 Company 2 Genetic Engineering Drug Products Offered | |
| 12.2.5 Company 2 Recent Development | |
12.3 Company 3 |
|
| 12.3.1 Company 3 Corporation Information | |
| 12.3.2 Company 3 Description and Business Overview | |
| 12.3.3 Company 3 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.3.4 Company 3 Genetic Engineering Drug Products Offered | |
| 12.3.5 Company 3 Recent Development | |
12.4 Company 4 |
|
| 12.4.1 Company 4 Corporation Information | |
| 12.4.2 Company 4 Description and Business Overview | |
| 12.4.3 Company 4 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.4.4 Company 4 Genetic Engineering Drug Products Offered | |
| 12.4.5 Company 4 Recent Development | |
12.5 Company 5 |
|
| 12.5.1 Company 5 Corporation Information | |
| 12.5.2 Company 5 Description and Business Overview | |
| 12.5.3 Company 5 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.5.4 Company 5 Genetic Engineering Drug Products Offered | |
| 12.5.5 Company 5 Recent Development | |
12.6 Company 6 |
|
| 12.6.1 Company 6 Corporation Information | |
| 12.6.2 Company 6 Description and Business Overview | |
| 12.6.3 Company 6 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.6.4 Company 6 Genetic Engineering Drug Products Offered | |
| 12.6.5 Company 6 Recent Development | |
12.7 Company 7 |
|
| 12.7.1 Company 7 Corporation Information | |
| 12.7.2 Company 7 Description and Business Overview | |
| 12.7.3 Company 7 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.7.4 Company 7 Genetic Engineering Drug Products Offered | |
| 12.7.5 Company 7 Recent Development | |
12.8 Company 8 |
|
| 12.8.1 Company 8 Corporation Information | |
| 12.8.2 Company 8 Description and Business Overview | |
| 12.8.3 Company 8 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.8.4 Company 8 Genetic Engineering Drug Products Offered | |
| 12.8.5 Company 8 Recent Development | |
12.9 Company 9 |
|
| 12.9.1 Company 9 Corporation Information | |
| 12.9.2 Company 9 Description and Business Overview | |
| 12.9.3 Company 9 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.9.4 Company 9 Genetic Engineering Drug Products Offered | |
| 12.9.5 Company 9 Recent Development | |
12.11 Company 1 |
|
| 12.11.1 Company 1 Corporation Information | |
| 12.11.2 Company 1 Description and Business Overview | |
| 12.11.3 Company 1 Genetic Engineering Drug Sales, Revenue and Gross Margin (2016-2021) | |
| 12.11.4 Company 1 Genetic Engineering Drug Products Offered | |
| 12.11.5 Company 1 Recent Development | |
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis |
|
13.1 Genetic Engineering Drug Industry Trends |
|
13.2 Genetic Engineering Drug Market Drivers |
|
13.3 Genetic Engineering Drug Market Challenges |
|
13.4 Genetic Engineering Drug Market Restraints |
|
14 Value Chain and Sales Channels Analysis |
|
14.1 Value Chain Analysis |
|
14.2 Genetic Engineering Drug Customers |
|
14.3 Sales Channels Analysis |
|
| 14.3.1 Sales Channels | |
| 14.3.2 Distributors | |
15 Research Findings and Conclusion |
|
16 Appendix |
|
16.1 Research Methodology |
|
| 16.1.1 Methodology/Research Approach | |
| 16.1.2 Data Source | |
16.2 Author Details |
|
16.3 Disclaimer |
|
| List of Tables | |
| Table 1. Global Genetic Engineering Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) | |
| Table 2. Major Manufacturers of Monoclonal Antibody | |
| Table 3. Major Manufacturers of Recombinant Human Erythropoietin | |
| Table 4. Major Manufacturers of Recombinant Human Interferon | |
| Table 5. Major Manufacturers of Recombinant Human Growth Hormone | |
| Table 6. Major Manufacturers of Recombinant Human Insulin | |
| Table 7. Global Genetic Engineering Drug Market Size Growth Rate by Application (2021-2027) & (K Units) | |
| Table 8. Global Genetic Engineering Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 | |
| Table 9. Global Genetic Engineering Drug Sales by Regions (2016-2021) & (K Units) | |
| Table 10. Global Genetic Engineering Drug Sales Market Share by Regions (2016-2021) | |
| Table 11. Global Genetic Engineering Drug Revenue by Regions (2016-2021) & (US$ Million) | |
| Table 12. Global Genetic Engineering Drug Sales Forecast by Region (2022-2027) & (K Units) | |
| Table 13. Global Genetic Engineering Drug Sales Market Share Forecast by Region (2022-2027) | |
| Table 14. Global Genetic Engineering Drug Revenue Forecast by Region (2022-2027) & (US$ Million) | |
| Table 15. Global Genetic Engineering Drug Revenue Market Share Forecast by Region (2022-2027) | |
| Table 16. Global Genetic Engineering Drug Sales by Manufacturers (2016-2021) (K Units) | |
| Table 17. Global Genetic Engineering Drug Sales Share by Manufacturers (2016-2021) | |
| Table 18. Ranking of Global Top Genetic Engineering Drug Manufacturers by Revenue (US$ Million) in 2020 | |
| Table 19. Genetic Engineering Drug Revenue by Manufacturers (2016-2021) (US$ Million) | |
| Table 20. Genetic Engineering Drug Revenue Share by Manufacturers (2016-2021) | |
| Table 21. Global Genetic Engineering Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) | |
| 2021-2027全球和日本基因工程藥業分析和趨勢報告 | |
| Table 22. Global Genetic Engineering Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Engineering Drug as of 2020) | |
| Table 23. Key Manufacturers Genetic Engineering Drug Price (2016-2021) (USD/Unit) | |
| Table 24. Genetic Engineering Drug Manufacturers Manufacturing Base Distribution and Headquarters | |
| Table 25. Manufacturers Genetic Engineering Drug Product Type | |
| Table 26. Date of International Manufacturers Enter into Genetic Engineering Drug Market | |
| Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans | |
| Table 28. Global Genetic Engineering Drug Sales by Type (2016-2021) (K Units) | |
| Table 29. Global Genetic Engineering Drug Sales Share by Type (2016-2021) | |
| Table 30. Global Genetic Engineering Drug Revenue by Type (2016-2021) (US$ Million) | |
| Table 31. Global Genetic Engineering Drug Revenue Share by Type (2016-2021) | |
| Table 32. Genetic Engineering Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) | |
| Table 33. Global Genetic Engineering Drug Sales Forecast by Type (2022-2027) & (K Units) | |
| Table 34. Global Genetic Engineering Drug Sales Market Share Forecast by Type (2022-2027) | |
| Table 35. Global Genetic Engineering Drug Revenue Forecast V (2022-2027) & (US$ Million) | |
| Table 36. Global Genetic Engineering Drug Revenue Market Share Forecast by Type (2022-2027) | |
| Table 37. Global Genetic Engineering Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) | |
| Table 38. Global Genetic Engineering Drug Sales by Application (2016-2021) (K Units) | |
| Table 39. Global Genetic Engineering Drug Sales Share by Application (2016-2021) | |
| Table 40. Global Genetic Engineering Drug Revenue by Application (2016-2021) (US$ Million) | |
| Table 41. Global Genetic Engineering Drug Revenue Share by Application (2016-2021) | |
| Table 42. Genetic Engineering Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) | |
| Table 43. Global Genetic Engineering Drug Sales Forecast by Application (2022-2027) & (K Units) | |
| Table 44. Global Genetic Engineering Drug Sales Market Share Forecast by Application (2022-2027) | |
| Table 45. Global Genetic Engineering Drug Revenue Forecast by Application (2022-2027) & (US$ Million) | |
| Table 46. Global Genetic Engineering Drug Revenue Market Share Forecast by Application (2022-2027) | |
| Table 47. Global Genetic Engineering Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) | |
| Table 48. Japan Genetic Engineering Drug Sales (K Units) of Key Companies (2016-2021) | |
| Table 49. Japan Genetic Engineering Drug Sales Share by Company (2016-2021) | |
| Table 50. Japan Genetic Engineering Drug Revenue (US$ Million) by Company (2016-2021) | |
| Table 51. Japan Genetic Engineering Drug Revenue Share by Company (2016-2021) | |
| Table 52. Japan Genetic Engineering Drug Sales (K Units) by Type (2016-2021) | |
| Table 53. Japan Genetic Engineering Drug Sales Share by Type (2016-2021) | |
| Table 54. Japan Genetic Engineering Drug Revenue (US$ Million) Market Share by Type (2016-2021) | |
| Table 55. Japan Genetic Engineering Drug Price (USD/Unit) by Type (2016-2021) | |
| Table 56. Japan Genetic Engineering Drug Sales (K Units) by Type (2022-2027) | |
| Table 57. Japan Genetic Engineering Drug Sales Share by Type (2022-2027) | |
| Table 58. Japan Genetic Engineering Drug Revenue (US$ Million) Market Share by Type (2022-2027) | |
| Table 59. Japan Genetic Engineering Drug Revenue Share by Type (2022-2027) | |
| Table 60. Japan Genetic Engineering Drug Price (USD/Unit) by Type (2022-2027) | |
| Table 61. Japan Genetic Engineering Drug Sales (K Units) by Application (2016-2021) | |
| Table 62. Japan Genetic Engineering Drug Sales Share by Application (2016-2021) | |
| Table 63. Japan Genetic Engineering Drug Revenue (US$ Million) Market Share by Application (2016-2021) | |
| Table 64. Japan Genetic Engineering Drug Price (USD/Unit) by Application (2016-2021) | |
| Table 65. Japan Genetic Engineering Drug Sales (K Units) by Application (2022-2027) | |
| Table 66. Japan Genetic Engineering Drug Sales Share by Application (2022-2027) | |
| Table 67. Japan Genetic Engineering Drug Revenue (US$ Million) Market Share by Application (2022-2027) | |
| Table 68. Japan Genetic Engineering Drug Revenue Share by Application (2022-2027) | |
| Table 69. Japan Genetic Engineering Drug Price (USD/Unit) by Application (2022-2027) | |
| Table 70. North America Genetic Engineering Drug Sales by Country (2016-2021) & (K Units) | |
| Table 71. North America Genetic Engineering Drug Sales Market Share by Country (2016-2021) | |
| Table 72. North America Genetic Engineering Drug Revenue by Country (2016-2021) & (US$ Million) | |
| Table 73. North America Genetic Engineering Drug Revenue Market Share by Country (2016-2021) | |
| Table 74. Asia Pacific Genetic Engineering Drug Sales by Region (2016-2021) & (K Units) | |
| Table 75. Asia Pacific Genetic Engineering Drug Sales Market Share by Region (2016-2021) | |
| Table 76. Asia Pacific Genetic Engineering Drug Revenue by Region (2016-2021) & (US$ Million) | |
| Table 77. Asia Pacific Genetic Engineering Drug Revenue Market Share by Region (2016-2021) | |
| Table 78. Europe Genetic Engineering Drug Sales by Country (2016-2021) & (K Units) | |
| Table 79. Europe Genetic Engineering Drug Sales Market Share by Country (2016-2021) | |
| Table 80. Europe Genetic Engineering Drug Revenue by Country (2016-2021) & (US$ Million) | |
| Table 81. Europe Genetic Engineering Drug Revenue Market Share by Country (2016-2021) | |
| Table 82. Latin America Genetic Engineering Drug Sales by Country (2016-2021) & (K Units) | |
| Table 83. Latin America Genetic Engineering Drug Sales Market Share by Country (2016-2021) | |
| Table 84. Latin Americaa Genetic Engineering Drug Revenue by Country (2016-2021) & (US$ Million) | |
| Table 85. Latin America Genetic Engineering Drug Revenue Market Share by Country (2016-2021) | |
| Table 86. Middle East and Africa Genetic Engineering Drug Sales by Country (2016-2021) & (K Units) | |
| Table 87. Middle East and Africa Genetic Engineering Drug Sales Market Share by Country (2016-2021) | |
| Table 88. Middle East and Africa Genetic Engineering Drug Revenue by Country (2016-2021) & (US$ Million) | |
| Table 89. Middle East and Africa Genetic Engineering Drug Revenue Market Share by Country (2016-2021) | |
| Table 90. Company 1 Corporation Information | |
| Table 91. Company 1 Description and Business Overview | |
| Table 92. Company 1 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 93. Company 1 Genetic Engineering Drug Product | |
| Table 94. Company 1 Recent Development | |
| Table 95. Company 2 Corporation Information | |
| Table 96. Company 2 Description and Business Overview | |
| Table 97. Company 2 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 98. Company 2 Product | |
| Table 99. Company 2 Recent Development | |
| Table 100. Company 3 Corporation Information | |
| Table 101. Company 3 Description and Business Overview | |
| Table 102. Company 3 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 103. Company 3 Product | |
| Table 104. Company 3 Recent Development | |
| Table 105. Company 4 Corporation Information | |
| Table 106. Company 4 Description and Business Overview | |
| Table 107. Company 4 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 108. Company 4 Product | |
| Table 109. Company 4 Recent Development | |
| Table 110. Company 5 Corporation Information | |
| Table 111. Company 5 Description and Business Overview | |
| Table 112. Company 5 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 113. Company 5 Product | |
| Table 114. Company 5 Recent Development | |
| Table 115. Company 6 Corporation Information | |
| Table 116. Company 6 Description and Business Overview | |
| 2021-2027 quánqiú hé rìběn jīyīn gōngchéng yào yè fēnxī hé qūshì bàogào | |
| Table 117. Company 6 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 118. Company 6 Product | |
| Table 119. Company 6 Recent Development | |
| Table 120. Company 7 Corporation Information | |
| Table 121. Company 7 Description and Business Overview | |
| Table 122. Company 7 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 123. Company 7 Product | |
| Table 124. Company 7 Recent Development | |
| Table 125. Company 8 Corporation Information | |
| Table 126. Company 8 Description and Business Overview | |
| Table 127. Company 8 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 128. Company 8 Product | |
| Table 129. Company 8 Recent Development | |
| Table 130. Company 9 Corporation Information | |
| Table 131. Company 9 Description and Business Overview | |
| Table 132. Company 9 Genetic Engineering Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) | |
| Table 133. Company 9 Product | |
| Table 134. Company 9 Recent Development | |
| Table 135. Genetic Engineering Drug Market Trends | |
| Table 136. Genetic Engineering Drug Market Drivers | |
| Table 137. Genetic Engineering Drug Market Challenges | |
| Table 138. Genetic Engineering Drug Market Restraints | |
| Table 139. Genetic Engineering Drug Customers List | |
| Table 140. Genetic Engineering Drug Distributors List | |
| Table 141. Research Programs/Design for This Report | |
| Table 142. Key Data Information from Secondary Sources | |
| Table 143. Key Data Information from Primary Sources | |
| List of Figures | |
| Figure 1. Genetic Engineering Drug Product Picture | |
| Figure 2. Global Genetic Engineering Drug Sales Market Share by Type in 2020 & 2027 | |
| Figure 3. Monoclonal Antibody Product Picture | |
| Figure 4. Recombinant Human Erythropoietin Product Picture | |
| Figure 5. Recombinant Human Interferon Product Picture | |
| Figure 6. Recombinant Human Growth Hormone Product Picture | |
| Figure 7. Recombinant Human Insulin Product Picture | |
| Figure 8. Global Genetic Engineering Drug Sales Market Share by Application in 2020 & 2027 | |
| Figure 9. Medicine | |
| Figure 10. Research | |
| Figure 11. Industrial | |
| Figure 12. Agriculture | |
| Figure 13. Other | |
| Figure 14. Genetic Engineering Drug Report Years Considered | |
| Figure 15. Global Genetic Engineering Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027 | |
| Figure 16. Global Genetic Engineering Drug Market Size 2016-2027 (US$ Million) | |
| Figure 17. Global Genetic Engineering Drug Sales 2016-2027 (K Units) | |
| Figure 18. Global Genetic Engineering Drug Market Size Market Share by Region: 2021 Versus 2027 | |
| Figure 19. Global Genetic Engineering Drug Sales Market Share by Region (2016-2021) | |
| Figure 20. Global Genetic Engineering Drug Sales Market Share by Region in 2020 | |
| Figure 21. Global Genetic Engineering Drug Revenue Market Share by Region (2016-2021) | |
| Figure 22. Global Genetic Engineering Drug Revenue Market Share by Region in 2020 | |
| Figure 23. Global Genetic Engineering Drug Sales Share by Manufacturer in 2020 | |
| Figure 24. The Top 10 and 5 Players Market Share by Genetic Engineering Drug Revenue in 2020 | |
| Figure 25. Genetic Engineering Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 | |
| Figure 26. Global Genetic Engineering Drug Sales Market Share by Type (2016-2021) | |
| Figure 27. Global Genetic Engineering Drug Sales Market Share by Type in 2020 | |
| Figure 28. Global Genetic Engineering Drug Revenue Market Share by Type (2016-2021) | |
| Figure 29. Global Genetic Engineering Drug Revenue Market Share by Type in 2020 | |
| Figure 30. Global Genetic Engineering Drug Sales Market Share by Application (2016-2021) | |
| Figure 31. Global Genetic Engineering Drug Sales Market Share by Application in 2020 | |
| Figure 32. Global Genetic Engineering Drug Revenue Market Share by Application (2016-2021) | |
| Figure 33. Global Genetic Engineering Drug Revenue Market Share by Application in 2020 | |
| Figure 34. Japan Genetic Engineering Drug Sales Growth Rate 2016-2027 (K Units) | |
| Figure 35. Japan Genetic Engineering Drug Revenue Growth Rate 2016-2027 (US$ Million) | |
| Figure 36. Japan Genetic Engineering Drug Market Share in Global Market 2016-2027 | |
| Figure 37. Japan 5 and 10 Largest Genetic Engineering Drug Players Market Share by Revenue in Genetic Engineering Drug in 2020 | |
| Figure 38. Japan Genetic Engineering Drug Revenue Share by Type (2016-2021) | |
| Figure 39. Japan Genetic Engineering Drug Revenue Growth Rate by Type in 2016 & 2020 | |
| Figure 40. Japan Genetic Engineering Drug Revenue Share by Application (2016-2021) | |
| Figure 41. Japan Genetic Engineering Drug Revenue Growth Rate by Application in 2016 & 2020 | |
| Figure 42. North America Genetic Engineering Drug Sales Growth Rate 2016-2021 (K Units) | |
| Figure 43. North America Genetic Engineering Drug Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 44. North America Genetic Engineering Drug Sales Market Share by Country in 2020 | |
| Figure 45. North America Genetic Engineering Drug Revenue Market Share by Country in 2020 | |
| Figure 46. U.S. Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 47. U.S. Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 48. Canada Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 49. Canada Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 50. Europe Genetic Engineering Drug Sales Growth Rate 2016-2021 (K Units) | |
| Figure 51. Europe Genetic Engineering Drug Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 52. Europe Genetic Engineering Drug Sales Market Share by Country in 2020 | |
| Figure 53. Europe Genetic Engineering Drug Revenue Market Share by Country in 2020 | |
| Figure 54. Germany Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 55. Germany Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 56. France Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 57. France Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 58. U.K. Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 59. U.K. Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 60. Italy Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 61. Italy Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 62. Russia Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 63. Russia Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 64. Asia Pacific Genetic Engineering Drug Sales Growth Rate 2016-2021 (K Units) | |
| Figure 65. Asia Pacific Genetic Engineering Drug Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 66. Asia Pacific Genetic Engineering Drug Sales Market Share by Region in 2020 | |
| Figure 67. Asia Pacific Genetic Engineering Drug Revenue Market Share by Region in 2020 | |
| 2021-2027世界と日本遺伝子工學産業の分析と動向レポート | |
| Figure 68. China Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 69. China Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 70. Japan Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 71. Japan Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 72. South Korea Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 73. South Korea Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 74. India Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 75. India Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 76. Australia Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 77. Australia Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 78. Taiwan, China Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 79. Taiwan, China Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 80. Indonesia Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 81. Indonesia Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 82. Thailand Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 83. Thailand Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 84. Malaysia Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 85. Malaysia Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 86. Philippines Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 87. Philippines Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 88. Vietnam Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 89. Vietnam Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 90. Latin America Genetic Engineering Drug Sales Growth Rate 2016-2021 (K Units) | |
| Figure 91. Latin America Genetic Engineering Drug Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 92. Latin America Genetic Engineering Drug Sales Market Share by Country in 2020 | |
| Figure 93. Latin America Genetic Engineering Drug Revenue Market Share by Country in 2020 | |
| Figure 94. Mexico Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 95. Mexico Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 96. Brazil Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 97. Brazil Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 98. Argentina Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 99. Argentina Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 100. Middle East and Africa Genetic Engineering Drug Sales Growth Rate 2016-2021 (K Units) | |
| Figure 101. Middle East and Africa Genetic Engineering Drug Revenue Growth Rate 2016-2021 (US$ Million) | |
| Figure 102. Middle East and Africa Genetic Engineering Drug Sales Market Share by Country in 2020 | |
| Figure 103. Middle East and Africa Genetic Engineering Drug Revenue Market Share by Country in 2020 | |
| Figure 104. Turkey Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 105. Turkey Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 106. Saudi Arabia Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 107. Saudi Arabia Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 108. U.A.E Genetic Engineering Drug Sales Growth Rate (2016-2021) (K Units) | |
| Figure 109. U.A.E Genetic Engineering Drug Revenue Growth Rate (2016-2021) (US$ Million) | |
| Figure 110. Genetic Engineering Drug Value Chain | |
| Figure 111. Channels of Distribution | |
| Figure 112. Distributors Profiles | |
| Figure 113. Bottom-up and Top-down Approaches for This Report | |
| Figure 114. Data Triangulation | |
| Figure 115. Key Executives Interviewed | |
…
如需購買《2021-2027 Global and Japan Genetic Engineering Drug Industry Analysis and Trends Report》，編號：3112298
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號